Hypoglycemia: all 654 studies

Page 6 of 7. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.

• Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney DiseaseCompletedNCT02315300Not applicable
• The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against HypoglycemiaCompletedNCT02308293Not applicable
• Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal HypoglycemiaCompletedNCT02282254Phase 2
• Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.TerminatedNCT02244073Not applicable
• Diabetes Mellitus at the University Medical Center of MannheimStatus unknownNCT02241317
• A Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesCompletedNCT02230631
• Hypoglycemia in Hospitalized PatientsCompletedNCT02228642
• Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of HypoglycemiaCompletedNCT02225379Not applicable
• The Effects of Hypoglycaemia in People With Type 2 DiabetesCompletedNCT02205996Not applicable
• Insulin Degludec and Symptomatic Nocturnal HypoglycaemiaCompletedNCT02192450Phase 4
• Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care SettingTerminatedNCT02189395Phase 4
• Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in ChildrenCompletedNCT02179281Not applicable
• Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration TrialCompletedNCT02176096Not applicable
• The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood FlowCompletedNCT02146404Not applicable
• Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed LoopCompletedNCT02135068Early Phase 1
• New Imaging Procedure for the Localisation of InsulinomaCompletedNCT02127541Not applicable
• Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.WithdrawnNCT02109315Phase 1
• Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 DiabetesCompletedNCT02107326Not applicable
• Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)CompletedNCT02086227Phase 1
• Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or HemodialysisCompletedNCT02083133
• Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 DiabetesCompletedNCT02068638Not applicable
• The Role of 1.5-anhydro-D-glucitol as Clinical Biomarkers of Hypoglycemia in Patients With DiabetesCompletedNCT02068300
• Carbohydrates to Prevent Hypoglycaemia During Physical Activity in Patients With Type 1 DiabetesCompletedNCT02057848Not applicable
• Multicentre LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness (LOGIC-2)CompletedNCT02056353Not applicable
• Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter LigandCompletedNCT02056249
• Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes CareCompletedNCT02025296Not applicable
• Study on Lixisenatide and Counterregulation to HypoglycemiaCompletedNCT02020629Phase 4
• Real-time Continuous Glucose Monitoring in Very Low Birth Weight NeonatesCompletedNCT01942239Not applicable
• Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi Dose InjectionCompletedNCT01941238
• Post-Gastric Bypass HypoglycemiaCompletedNCT01933490Not applicable
• Preventing HypoglycemiaCompletedNCT01923688Not applicable
• DPP4inhibitors in Type 1 DiabetesCompletedNCT01922817Phase 3
• Intracellular Counter-regulatory Mechanisms Following Low Blood GlucoseCompletedNCT01919788Not applicable
• Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize HypoglycemiaCompletedNCT01919385Phase 1
• Islet Cell Transplant for Type 1 DiabetesActive, not recruitingNCT01909245Phase 2
• Hypoglycemia in Prader-Willi SyndromeCompletedNCT01897363
• Etiology, Assessment and Treatment of Post-gastric Bypass Severe HypoglycemiaCompletedNCT01865760Not applicable
• GLP-1 and HypoglycemiaActive, not recruitingNCT01858896Early Phase 1
• Hippocampal Metabolism and Function in Patients With Type 1 DiabetesCompletedNCT01852968
• Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 DiabetesStatus unknownNCT01840358Not applicable
• Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 DiabetesWithdrawnNCT01828125Phase 2
• A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 DiabetesCompletedNCT01789593Phase 1
• The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHACompletedNCT01787903Not applicable
• A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 DiabetesCompletedNCT01780272Phase 1
• GIP and GLP-1 in Type 1 DiabetesCompletedNCT01739283Not applicable
• Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose MonitoringCompletedNCT01714895Not applicable
• An International Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesCompletedNCT01696266
• Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal HypoglycemiaTerminatedNCT01688674Not applicable
• Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in HumansTerminatedNCT01660009Not applicable
• French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic PatientsCompletedNCT01628341
• Islet Transplant for Type 1 or Surgical DiabetesNo longer availableNCT01606475
• Bariatric Surgery and Reactive HypoglycemiaCompletedNCT01581801Not applicable
• Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)CompletedNCT01563887Not applicable
• The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 DiabetesCompletedNCT01536665Phase 1
• Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill PatientsCompletedNCT01526044Not applicable
• Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus PatientsStatus unknownNCT01525784
• A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DMCompletedNCT01523405
• MDRS for Prevention of Nocturnal HypoglycemiaCompletedNCT01509157Phase 1
• Use of Diazoxide in Acute HypoglycaemiaCompletedNCT01488136Phase 4
• Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01487798Phase 4
• GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 DiabetesCompletedNCT01414556Early Phase 1
• Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research SettingCompletedNCT01401751Not applicable
• Lactate to Treat HypoglycemiaWithdrawnNCT01387477Phase 4
• Acute Maternal and Fetal Effects of Exercise in PregnancyCompletedNCT01383889Not applicable
• Therapeutic Education in Very Young Children With Diabetes MellitusCompletedNCT01354288Not applicable
• Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1CompletedNCT01347801Not applicable
• Recurrent Hypoglycaemia in Type 1 DiabetesCompletedNCT01337362Not applicable
• Pilot Study of Intensive Care Unit Continuous Glucose MonitoringStatus unknownNCT01301053Not applicable
• Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and RecoveryCompletedNCT01283126Not applicable
• Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.TerminatedNCT01244646
• Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - a Pilot StudyTerminatedNCT01238016Not applicable
• EEG Changes of type1 Diabetes During Sleep -Insulin Induced HypoglycemiaCompletedNCT01237509
• Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 DiabetesCompletedNCT01219400Phase 4
• Prevention of Severe Hypoglycaemia With Hypo-Safe Hypoglycaemia Alarm DeviceWithdrawnNCT01178476Not applicable
• Hypoglycemia: Physician and Patient PerspectivesCompletedNCT01176656
• Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 DiabetesCompletedNCT01147276Phase 4
• Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney TransplantationCompletedNCT01123187Not applicable
• Pediatric Critical Illness Hyperglycemia and Glycemic Control RegistryCompletedNCT01116674
• Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin SystemCompletedNCT01116180Not applicable
• B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft FailureNo longer availableNCT01049633
• Identification of Inpatients at Risk for Poor Glycemic ControlCompletedNCT01043042
• Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic UnawarenessWithdrawnNCT01029639Phase 2/3
• Investigating the Accuracy of the Home Glucose Monitors in HypoglycemiaCompletedNCT01013402Phase 4
• Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid ResponseCompletedNCT01005342Not applicable
• Diazoxide In the Management Of Hypoglycemic NeonatesStatus unknownNCT00994149Phase 2/3
• Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 DiabetesCompletedNCT00993720Phase 2/3
• Whole Body 111In-exendin-4 Imaging Study in Insulinoma PatientsCompletedNCT00937079
• Neurocognitive Impact of Hypoglycemia in Type 1 DiabetesCompletedNCT00916838
• GLP 1 for Intraoperative Glycemic ControlCompletedNCT00882492Phase 1
• Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to DysinsulinismCompletedNCT00847080Phase 4
• International Navigator Hypoglycaemia StudyCompletedNCT00843609Not applicable
• To Evaluate the Response to Glucagon During HypoglycemiaCompletedNCT00817271Phase 1
• EEG-Changes During Insulininduced Hypoglycemia in Type 1 DiabetesCompletedNCT00810420
• Octreotide for the Treatment of Sulfonylurea-Associated HypoglycemiaCompletedNCT00804297Phase 3
• Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-OligosaccharideCompletedNCT00802971Not applicable
• Reversal of Hypoglycemia Unawareness Using Continuous Glucose MonitoringWithdrawnNCT00796848Not applicable
• Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia UnawarenessCompletedNCT00793741
• Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-AtomoxetineCompletedNCT00780650Early Phase 1
• Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During RamadanTerminatedNCT00766441Phase 4
• Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy VolunteersCompletedNCT00745186Phase 1

← Hypoglycemia overview